Mcl-1 as a “barrier” in cancer treatment: can we target it now?
NV Pervushin, VV Senichkin, B Zhivotovsky… - International Review of …, 2020 - Elsevier
During the last two decades, the study of Mcl-1, an anti-apoptotic member of the Bcl-2 family,
attracted researchers due to its important role in cancer cell survival and tumor development …
attracted researchers due to its important role in cancer cell survival and tumor development …
[PDF][PDF] Sorafenib resistance of hepatocellular carcinoma
M Meßner - 2020 - edoc.ub.uni-muenchen.de
Sorafenib represents the current standard of care for patients with advanced-stage
hepatocellular carcinoma (HCC). Nonetheless, its use is hampered by the frequent …
hepatocellular carcinoma (HCC). Nonetheless, its use is hampered by the frequent …
[引用][C] Sorafenib resistance of hepatocellular carcinoma: antibiotics second-line to Sorafenib therapy inhibit mitochondrial biogenesis and prevent tumor growth …
M Meßner - 2020 - Dissertation, München, Ludwig …